BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32051302)

  • 21. Trade-offs between overall survival and side effects in the treatment of metastatic breast cancer: eliciting preferences of patients with primary and metastatic breast cancer using a discrete choice experiment.
    Bullen A; Ryan M; Ennis H; Gray E; Loría-Rebolledo LE; McIntyre M; Hall P
    BMJ Open; 2024 Apr; 14(4):e076798. PubMed ID: 38684245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrete choice experiment to estimate breast cancer patients' preferences and willingness to pay for prophylactic granulocyte colony-stimulating factors.
    Johnson P; Bancroft T; Barron R; Legg J; Li X; Watson H; Naeim A; Watkins A; Marshall DA
    Value Health; 2014 Jun; 17(4):380-9. PubMed ID: 24968998
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment preferences of patients with relapsed or refractory multiple myeloma in the United States, United Kingdom, Italy, Germany, France, and Spain: results from a discrete choice experiment.
    Thomas C; Ailawadhi S; Popat R; Kleinman D; Ross MM; Gorsh B; Mulnick S; O'Neill A; Paka P; Hanna M; Krucien N; Molinari A; Gelhorn HL; Perera S
    Front Med (Lausanne); 2023; 10():1271657. PubMed ID: 38076274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing the Relative Importance of Attributes of Metastatic Renal Cell Carcinoma Treatments to Patients and Physicians in the United States: A Discrete-Choice Experiment.
    González JM; Doan J; Gebben DJ; Boeri M; Fishman M
    Pharmacoeconomics; 2018 Aug; 36(8):973-986. PubMed ID: 29869777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of Patient Preferences in Lung Cancer - Estimating Acceptable Tradeoffs Between Treatment Benefit and Side Effects.
    Janssen EM; Dy SM; Meara AS; Kneuertz PJ; Presley CJ; Bridges JFP
    Patient Prefer Adherence; 2020; 14():927-937. PubMed ID: 32581519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients' preferences: a discrete-choice experiment for treatment of non-small-cell lung cancer.
    Mühlbacher AC; Bethge S
    Eur J Health Econ; 2015 Jul; 16(6):657-70. PubMed ID: 25135768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom.
    Qian Y; Arellano J; Gatta F; Hechmati G; Hauber AB; Mohamed AF; Bahl A; von Moos R; Body JJ
    BMC Health Serv Res; 2018 Jul; 18(1):518. PubMed ID: 29970078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age at Diagnosis and Patient Preferences for Treatment Outcomes in AML: A Discrete Choice Experiment to Explore Meaningful Benefits.
    Richardson DR; Crossnohere NL; Seo J; Estey E; O'Donoghue B; Smith BD; Bridges JFP
    Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):942-948. PubMed ID: 32132149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of physicians' perspectives versus patients' preferences: direct assessment and discrete choice experiments in the therapy of multiple myeloma.
    Mühlbacher AC; Nübling M
    Eur J Health Econ; 2011 Jun; 12(3):193-203. PubMed ID: 20107856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Decisions for Advanced Non-Squamous Non-Small Cell Lung Cancer: Patient and Physician Perspectives on Maintenance Therapy.
    McMullen S; Hess LM; Kim ES; Levy B; Mohamed M; Waterhouse D; Wozniak A; Goring S; Müller K; Muehlenbein C; Aggarwal H; Zhu Y; Oton AB; Ersek JL; Winfree KB
    Patient; 2019 Apr; 12(2):223-233. PubMed ID: 30128728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessment of patients' preferences for new anticancer drugs in China: a best-worst discrete choice experiment on three common cancer types.
    Feng Z; Meng J; Sun Y; Xie T; Lu W; Wang G; Geng J
    BMJ Open; 2023 Jun; 13(6):e072469. PubMed ID: 37270199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' preferences for osteoporosis drug treatment: a discrete-choice experiment.
    Hiligsmann M; Dellaert BG; Dirksen CD; van der Weijden T; Goemaere S; Reginster JY; Watson V; Boonen A
    Arthritis Res Ther; 2014 Jan; 16(1):R36. PubMed ID: 24479410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient preferences in advanced or recurrent ovarian cancer.
    Havrilesky LJ; Alvarez Secord A; Ehrisman JA; Berchuck A; Valea FA; Lee PS; Gaillard SL; Samsa GP; Cella D; Weinfurt KP; Abernethy AP; Reed SD
    Cancer; 2014 Dec; 120(23):3651-9. PubMed ID: 25091693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preferences for End-of-Life Care Among Patients With Terminal Cancer in China.
    Leng A; Maitland E; Wang S; Nicholas S; Lan K; Wang J
    JAMA Netw Open; 2022 Apr; 5(4):e228788. PubMed ID: 35467732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Collecting Physicians' Preferences on Medical Devices: Are We Doing It Right? Evidence from Italian Orthopedists Using 2 Different Stated Preference Methods.
    Armeni P; Meregaglia M; Borsoi L; Callea G; Torbica A; Benazzo F; Tarricone R
    Med Decis Making; 2023; 43(7-8):886-900. PubMed ID: 37837325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantifying Physician Preferences for Systemic Atopic Dermatitis Treatments Using a Discrete-Choice Experiment.
    Carrascosa Carrillo JM; Baselga Torres E; Gilaberte Calzada Y; Jurgens Martínez YN; Roustan Gullón G; Yanguas Bayona JI; Gómez Castro S; Ferrario MG; Rebollo Laserna FJ
    Dermatol Ther (Heidelb); 2022 May; 12(5):1197-1210. PubMed ID: 35445962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Choosing Video Instead of In-Clinic Consultations in Primary Care in Israel: Discrete Choice Experiment Among Key Stakeholders-Patients, Primary Care Physicians, and Policy Makers.
    Chudner I; Drach-Zahavy A; Karkabi K
    Value Health; 2019 Oct; 22(10):1187-1196. PubMed ID: 31563262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient Preference for Antiepileptic Drugs Treatment in China: Evidence From the Discrete Choice Experiment.
    Hua Y; Zhu Z; Li X; Gong J; Ding S; Lin J; Wang X; Du Y; Xia N; Zheng R; Xu H
    Front Neurol; 2020; 11():602481. PubMed ID: 33343502
    [No Abstract]   [Full Text] [Related]  

  • 39. Patient Preferences For Specialty Pharmacy Services: A Stated Preference Discrete-Choice Experiment in China.
    Hu Q; Hu H; Hu M; Yang Y; Wu Z; Zhou N
    Front Public Health; 2020; 8():597389. PubMed ID: 33363089
    [No Abstract]   [Full Text] [Related]  

  • 40. What Do Patients Want from Otolaryngologists? A Discrete Choice Experiment.
    Naunheim MR; Rathi VK; Naunheim ML; Alkire BC; Lam AC; Song PC; Shrime MG
    Otolaryngol Head Neck Surg; 2017 Oct; 157(4):618-624. PubMed ID: 28675119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.